Jupiter Neurosciences JUNS
NASDAQ JUNS
$6.20 +1.03 (+19.92%)
At close: Aug 21, 2026 · 4:00 PM EDT

Jupiter Neurosciences (JUNS) Shares Outstanding (Diluted) (2023 - 2025)

Jupiter Neurosciences (JUNS) Shares Outstanding (Diluted) (2023 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 64.41 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 398.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 115.80 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 138.28 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 241.70 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 217.35 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 556.90 Mn
10 Jupiter Neurosciences 3.37 Mn 1.85 Mn 21,064.00 557,567.00

Historic Data

Download Data
DateValue
Dec 31, 2025 34.63 Mn
Sep 30, 2025 34.04 Mn
Jun 30, 2025 33.18 Mn
Mar 31, 2025 33.10 Mn
Dec 31, 2024 28.78 Mn
Sep 30, 2024 31.07 Mn
Jun 30, 2024 30.59 Mn
Mar 31, 2024 26.53 Mn
Dec 31, 2023 26.41 Mn
Sep 30, 2023 26.40 Mn